Problems of emotion and motivation

13 Problems of emotion and motivation






Introduction


Many neurological conditions in which the brain is affected are associated with changes in emotion, mood and motivation (Cappa 2001). For many patients and their families, the emotional ‘fallout’ of a neurological condition may be one of the most difficult problems they have to cope with. Health professionals working with patients who experience emotional distress may also find this to be challenging.


Despite the prominent place that emotion occupies in the lives of most of us, the scientific study of ‘emotion’ was neglected for a considerable period of time. The main barriers were that it was problematic to define ‘emotion’ in the first place, while traditional methods used to study the topic (e.g. introspection) were criticised for being ‘unscientific’. Instead, the realm of emotion was considered to belong to artists, who – with prose and poetry, on canvas and through music – were considered to be much more capable of conveying emotion and its impact than any scientist. As a result, the scientific exploration of ‘emotion’ lay dormant until relatively recently, when neuro imaging technology emerged. An exciting era lay ahead; for the first time, scientists and clinicians were able to explore the neural correlates of emotion and mental illness such as depression and schizophrenia. As a result, scientific activity in this topic area has soared. However, ‘emotion’ is often neglected in textbooks of cognitive psychology. Given the prevalence and impact of emotional difficulties in people with neurological conditions, it is important that health-care professionals have a good understanding of this topic.


The aim of this chapter is to explore what is meant by ‘emotion’ and whether this is a purely personal experience that defies generalisation. Given its common occurrence in the general population, as well as in people with neurological conditions, we will then move on to discuss depression, its possible causes and treatment options in more detail. This will be followed by an introduction to some of the most frequently reported difficulties with emotion and motivation in people with stroke, traumatic brain injury (TBI), Parkinson’s disease (PD) and Alzheimer’s disease (AD). We will discuss various explanations for problems with emotion and motivation, beginning with a biomedical perspective – by investigating neurological consequences of the various conditions and identifying those brain areas and physiological processes that play a key role in emotion and motivation. We will then move on to a more psychosocial perspective by exploring how neurological conditions may affect the lives, experiences and aspirations of those affected – and the impact of coping strategies and social support. Finally, we will refer back to the previous chapter on executive function and explore how an intricate integration between executive function and emotion is required for rational behaviour that serves the survival of the individual.


Our intention is that this information will enable you to have a better understanding of, and empathy for, the patients and the families with whom you will be working.



Emotion: an overview



Emotion: can it be defined?


What is emotion? Try for a moment to remember an emotionally rich event in your life. Graduations are a useful example, where people typically feel intensely proud, experience a rush of pleasure and excitement, believe that the world is full of promise, and throw their mortar boards in the air, out of sheer joy. It is difficult to unpick this complex experience, but basically it comprises the following responses:



A physiological response to an emotionally intense life event at the other end of the spectrum could be a frightening situation, such as a house fire. This situation would involve the release of stress hormones (e.g. cortisol), activation of the sympathetic nervous system and a preparation of the musculoskeletal system for a fright, flight or fight reaction. A psychological response in such a scenario could be your belief that you’re in imminent danger, which in turn motivates you to flee, while a typical behavioural reaction would be to scream for help, adopt a defensive posture and run for safety.


Some psychologists have made attempts to define emotion. Here is an example by Smith (1993):



Although this is a very inclusive description, one could argue that its broadness jeopardises its specificity. It is probably more useful to have an understanding of different types of emotion, than to worry about comprehensively capturing this complex concept.


When we think of an emotion, we may be inclined to think that this is unique to each of us – specific to our own individual world of experience only. Although it is attractive to indulge in the notion of a strictly private world, ground-breaking work by Darwin in the 1850s confirmed that there are around six basic facial expressions, each conveying a distinct emotion, which are understood the world over (Darwin 1865, cited in Berthoz 2003). These universal facial expressions communicate:



Pioneering work by anthropologist Ekman in Papua New Guinea, where until that time no Westerner had set foot, confirmed these basic emotions; when told an emotionally charged story and asked to express what this felt like, local inhabitants showed facial expressions that could readily be understood by people from Western civilisations (Ekman 1984).


This universality in basic emotions makes sense from the perspective of survival: before the arrival of the communication technologies we use today, facial expressions were our primary means of communicating to our immediate social network how we felt. If there is danger, communicating fear is essential to warn others around us. Disgust may signal food that is inedible, while an angry face conveys a warning. This universality suggests that some of our emotional expressions are ‘hardwired’ in the brain – a topic we will come to later.


We will now turn to the topic of depression, one of the most common mental health problems in both the general population, and in people with long-term neurological conditions.



Depression


The group of conditions known as the affective disorders involve a disturbance of mood (with associated cognitive and emotional symptoms) associated with changes in behaviour, energy, appetite and sleep (the biological symptoms). Changes in our mood are regular occurrences and it is the highs and lows that we experience that give depth to our emotional existence. If we have had a bad day at work or university, then we will enjoy a relaxing and fun time with our friends all the more. So, ups and downs in our mood are not a bad thing, however if our mood strays to the pathological extremes of the normal continuum then that can result in significant problems. These pathological extremes can be manifest as either extreme excitement and elation (mania) or severe depression, or a swing between both. The affective disorders can be classified into two types: unipolar (mania or depression) and bipolar (manic depression). As depression is the more common phenomenon to manifest itself after an injury or illness then we shall focus on that for the purpose of this chapter. Among the more common features of depression are:




Classification of depression


Depression comes in different forms. It used to be thought that depression could be simply classified in two ways – reactive and endogenous. With reactive depression there is usually a very specific, clear psychological cause (e.g. a bereavement, the loss of a job, the break-up of a long-term relationship). This type of reactive change may occur following, for example, a stroke where the patient has had a significant loss of function and is no longer able to engage in certain activities and life roles that they were able to do pre-stroke. Unlike reactive depression, there appeared to be no clear cause for endogenous depression (hence the name). Patients suffering from endogenous depressions often express more severe symptoms (e.g. suicidal thoughts). It is important to correctly diagnose which form of depression an individual has, as evidence suggests that endogenous depression responds better to drug therapy (see later in this chapter).


An alternative way to consider depression is to classify the level of disability produced as being either a major depression or a dysthymia. A major depression will interfere quite markedly with the individual’s ability to work, study, sleep, eat or enjoy pleasurable activities. Such a level of dysfunction may only occur once, but it is quite common for such a disturbance to occur on multiple occasions throughout life. Chronic major depression of this nature may require an extensive period of appropriate treatment. Dysthymic disorder, or dysthymia, produces symptoms of a less severe nature; however, they can still be chronic and long-lasting. Dysthymia does not necessarily seriously disable the individual, but it can keep them from feeling and functioning well. It is also possible that a person with dysthymia may also experience a major depressive episode at some point in their life.



Causes of depression


The actual cause of depression is still unknown. In some families it can be apparent that depression occurs from generation to generation, however, it can also occur in a person with no family history of depressive illness. It is also widely accepted that depression is a combination of genetic, psychological, social and environmental factors.


Current biomedical views on the cause of depression centre round the monoamine hypothesis, which was first proposed in 1965 by Schildkraut. This hypothesis puts forward the idea that depression occurs as a consequence of abnormalities in the levels of the monoamine neurotransmitters (noradrenaline [NA], serotonin [5-HT]) in the limbic system. As mentioned in Chapter 2, the limbic system is the ‘emotional part’ of the brain and this system will be described more in detail below. Research points to particular evidence that reduced serotonergic neurotransmission is involved. It is hypothesised that depression is caused, in part, by a number of biochemical/pharmacological changes within the limbic system.


These changes include a lower level of monoamine transmitters (NA, 5-HT) and/or an upregulation of presynaptic autoreceptors (located on the presynaptic terminal) and somatodendritic autoreceptors (located on the dendrites of the presynaptic cell) that control monoamine release. This increase in the presynaptic receptors and those found on the dendrites result in an enhancement of the normal negative feedback mechanism, thereby causing a subsequent greater reduction in further monoamine release. Over time this mechanism would result in a significantly lower release of the transmitters.


There are a number of key pieces of evidence that both support and refute the monoamine theory.




Evidence against the monoamine theory


Despite the considerable evidence in support of the theory, there are some equally compelling arguments against the theory. There is a wide range of compounds that increase the availability of the monoamine transmitters (e.g. amphetamine, cocaine) but these agents have no ability to elevate the mood of depressed patients. It has also been noted that some of the atypical antidepressants work without affecting monoamine systems (e.g. trazodone or mirtazapine). The third, and final, piece of evidence that appears to suggest that there is more involved than the simple manipulation of the monoamine transmitters is the fact that there may be a ‘therapeutic delay’ of 2–3 weeks between the full neurochemical effects appearing and the start of the actual therapeutic effect.


As a consequence of the evidence that appears to refute the monoamine theory, it is possible to reach the conclusion that it is unlikely that monoamine systems alone are responsible for the symptoms of depression. A number of other systems that may be involved include GABA (γ-aminobutyric acid), neuropeptides (vasopressin, endogenous opiates) and various second messenger systems.


Having stated that other systems may be involved in the neuropharmacology of depression, it cannot be denied that some of the main, active anti-depressant drugs do indeed exert their therapeutic effect through the manipulation of monoamine systems. Some examples of drugs that work via monoamine systems are discussed below, although for a full list of all of the mechanistic approaches you should refer to one of the pharmacology texts suggested at the end of Chapter 4.



Treatment of depression


The mechanisms of action of the antidepressants covered next can be seen in Figure 13.1. This diagram shows a single synapse containing both NA and 5-HT, although in reality there would be either a noradrenergic synapse or a serotonergic synapse.








May 25, 2016 | Posted by in NEUROLOGY | Comments Off on Problems of emotion and motivation

Full access? Get Clinical Tree

Get Clinical Tree app for offline access